Skip to main content Skip to main navigation
Rijksoverheid logo | to homepage of RIVM National Institute for Public Health and the Environment Ministry of Health, Welfare and Sport
  • Nederlands
  • English
RIVM Committed to health and sustainability
  • Home
  • Topics
  • About RIVM
  • Publications
  • International
  • Contact
  • Agenda
  • MijnRIVM
  • Nederlands
  • English
  • Home
  • Search

Search

Skip searchoptions

Search

Fill in your search phrase.

Type

Selecting an option will change the focus to the start of the list.
  • Page (339)
  • News item (240)
  • Subject (30)
  • Blog post (7)
  • Activity (5)
  • Single page (3)

Publication date

Selecting an option will change the focus to the start of the list.
  • August 2026 (4)
  • July 2026 (7)
  • June 2026 (5)
  • May 2026 (4)
  • April 2026 (1)
  • March 2026 (7)
  • February 2026 (4)
  • January 2026 (2)
  • December 2025 (5)
  • November 2025 (6)
  • October 2025 (9)
  • September 2025 (7)
  • August 2025 (5)
  • July 2025 (2)
  • June 2025 (8)
  • May 2025 (3)
  • April 2025 (3)
  • March 2025 (2)
  • February 2025 (4)
  • January 2025 (6)
  • December 2024 (6)
  • November 2024 (4)
  • October 2024 (4)
  • September 2024 (2)
  • August 2024 (3)
  • July 2024 (4)
  • June 2024 (6)
  • May 2024 (9)
  • April 2024 (11)
  • March 2024 (5)
  • February 2024 (4)
  • December 2023 (11)
  • November 2023 (2)
  • October 2023 (3)
  • September 2023 (9)
  • August 2023 (1)
  • July 2023 (8)
  • June 2023 (4)
  • May 2023 (7)
  • April 2023 (11)
  • March 2023 (10)
  • February 2023 (8)
  • January 2023 (1)
  • December 2022 (5)
  • November 2022 (14)
  • October 2022 (10)
  • September 2022 (4)
  • August 2022 (3)
  • July 2022 (8)
  • June 2022 (1)
  • May 2022 (6)
  • April 2022 (3)
  • March 2022 (5)
  • February 2022 (6)
  • January 2022 (8)
  • December 2021 (38)
  • November 2021 (9)
  • October 2021 (3)
  • September 2021 (8)
  • August 2021 (6)
  • July 2021 (6)
  • June 2021 (26)
  • May 2021 (19)
  • April 2021 (15)
  • March 2021 (10)
  • February 2021 (9)
  • January 2021 (5)
  • December 2020 (6)
  • November 2020 (3)
  • September 2020 (5)
  • July 2020 (5)
  • June 2020 (7)
  • May 2020 (7)
  • April 2020 (4)
  • March 2020 (8)
  • February 2020 (4)
  • January 2020 (6)
  • December 2019 (3)
  • November 2019 (3)
  • October 2019 (4)
  • September 2019 (2)
  • August 2019 (3)
  • July 2019 (2)
  • June 2019 (2)
  • May 2019 (3)
  • April 2019 (2)
  • March 2019 (2)
  • February 2019 (5)
  • January 2019 (3)
  • December 2018 (3)
  • November 2018 (11)
  • October 2018 (1)
  • August 2018 (1)
  • July 2018 (1)
  • May 2018 (1)
  • April 2018 (1)
  • February 2018 (3)
  • December 2017 (5)
  • November 2017 (3)
  • October 2017 (1)
  • September 2017 (3)
  • August 2017 (1)
  • May 2017 (1)
  • December 2016 (1)
  • October 2016 (1)
  • March 2016 (2)
  • January 2016 (1)
  • November 2015 (1)
  • July 2015 (2)
  • June 2015 (1)
  • April 2015 (2)
  • March 2015 (1)
  • January 2015 (4)
  • August 2014 (2)
  • July 2014 (1)
  • June 2014 (1)
  • February 2014 (2)
  • December 2013 (2)
  • November 2013 (1)
  • August 2013 (1)
  • July 2013 (1)
  • May 2013 (2)
  • March 2013 (2)
  • December 2012 (1)
  • November 2012 (1)
  • July 2012 (2)
  • March 2012 (1)
  • February 2012 (1)
  • January 2012 (5)
  • December 2011 (1)
  • November 2011 (11)
  • September 2011 (1)
  • August 2011 (1)
  • March 2011 (1)

Topics

Selecting an option will change the focus to the start of the list.
  • COVID-19 (75)
  • International (66)
  • Health research for COVID-19 (37)
  • International Research Projects (20)
  • Behavioural science (18)
  • Dutch Food Composition Database (NEVO) (15)
  • RIVM (14)
  • Food and Nutrition (11)
  • Dutch National Food Consumption Survey (9)
  • Mental Health (9)
  • Nanotechnology and advanced materials (9)
  • Respiratory infections (9)
  • Tick bites (8)
  • Sexually transmitted infections (STIs) (7)
  • Tobacco (7)
  • Wastewater research (7)
  • Infectious Disease Control (6)
  • National Immunisation Programme (6)
  • WHO Collaborating Centre for Laboratory Preparedness and Response for High Threat Pathogens and Biorisk (6)
  • Flu and flu vaccine (5)
  • Food safety (5)
  • Immunisation and vaccination (5)
  • WHO Collaborating Centre for Antimicrobial Resistance Epidemiology and Surveillance (5)
  • Zoonotic diseases (5)
  • Antimicrobial resistance (4)
  • ConsExpo (4)
  • Consumer exposure to chemical substances (4)
  • Ebola (4)
  • Gonorrhoea (4)
  • Population screening programs in the Caribbean Netherlands (4)
  • WHO Collaborating Centre for Nutrition (4)
  • WHO Collaborating Centre for Risk Assessment of Pathogens in Food and Water (4)
  • Breast Cancer Screening Programme (3)
  • Dengue (3)
  • Heat (3)
  • HPV (3)
  • Livestock farming and health (3)
  • Lyme disease (3)
  • Mosquitos (3)
  • Occupational Safety (3)
  • One Health (3)
  • Physical Activity (3)
  • Plastics (3)
  • Public Health Foresight (3)
  • Public Health Monitors (3)
  • Respiratory syncytial virus (RSV) (3)
  • Alternatives to animal testing (2)
  • Cervical cancer screening programme (2)
  • Chikungunya (2)
  • EU Reference Laboratory for Public Health on Vector-borne Viral Pathogens (EURL-PH-VBV) (2)
  • Hantavirus (2)
  • Malaria (2)
  • Measles (2)
  • Medical devices (2)
  • Meldpunt en Expertisecentrum Bijwerkingen Implantaten (2)
  • Mpox (2)
  • Nitrogen (2)
  • Pesticides and health effects (2)
  • PIENTER study (2)
  • Population screening programmes (2)
  • Scabies (2)
  • West Nile fever (2)
  • WHO Collaborating Centre for Infectious Disease Preparedness and IHR monitoring and evaluation (2)
  • Whooping cough (2)
  • Bird flu (avian influenza) (1)
  • Bisphenol A (BPA) (1)
  • Chickenpox (1)
  • Circular economy (1)
  • Contact (1)
  • Coronaviruses (1)
  • DNA and public health (1)
  • Global Health Security (1)
  • Health promotion (1)
  • Hepatitis B (1)
  • Impetigo (1)
  • Incidents and disasters (1)
  • International Health Information (1)
  • Lifestyle Monitor: public health monitoring of lifestyle and health in the Netherlands (1)
  • Marburg virus disease (1)
  • Medicinal products (1)
  • Meningococcal disease (1)
  • MERS (1)
  • Newborn hearing screening (1)
  • One Health (1)
  • Perinatal screening (1)
  • PFAS (1)
  • Pneumococci (1)
  • Polio (1)
  • Probit functions (1)
  • Rotavirus (1)
  • Rubber granulate (1)
  • Shigellosis (1)
  • Soil and water (1)
  • SPADE (1)
  • Sustainable Development Goals (1)
  • Sustainable procurement (1)
  • Tick-borne encephalitis (1)
  • Tuberculosis (1)
  • WHO Collaborating Centre for Tobacco Product Regulation and Control (1)
  • WHO Collaborating Centre on Chemical Food Safety (1)
  • Zika Virus (1)

636 search results

You searched for these word(s): VISIT buyfishscalecocaine.com BUY COCAINE POWDER ONLINE
  • Sustainable care and prevention (SPR 2019-2022)

    https://www.rivm.nl/en/about-rivm/knowledge-and-expertise/strategic-programme-rivm/2019-2022/sustainable-care-and-prevention

    … In the coming years, there will be changes in health care, both in … the health care system will continue to worsen during the upcoming period. Despite limited resources, the system must … health care system, as does the fact that health care is becoming increasingly personalised. The social challenge is to …

    Publication date: 08-16-2019
  • Newsletter on COVID-19 vaccination issue 2 2021

    https://www.rivm.nl/en/covid-19-vaccination/professionals/newsletter/2021/2

    … Upcoming events … Medicines Agency (EMA) issued a positive scientific recommendation for the second COVID-19 vaccine in the European … vaccine developed by Moderna. That same day, the European Commission announced that it had approved the vaccine for … guidelines provides a summary of the key changes compared to the previous version. Please note: adverse …

    Publication date: 01-14-2021
  • Issue 34

    https://www.rivm.nl/en/covid-19-vaccination/professionals/newsletter/2021/34

    … Public communication … Upcoming events … EMA’s human medicines committee (CHMP) has concluded that Spikevax (Moderna) can … 18 years and above. Earlier this month, it concluded that Comirnaty (Pfizer/BioNTech) can be used for the booster … here for answers to frequently asked questions about the combination of the flu jab, pneumococcal vaccination and …

    Publication date: 11-17-2021
  • Issue 30

    https://www.rivm.nl/en/covid-19-vaccination/professionals/newsletter/2021/30

    … Public communication … vaccine doses. The ECDC position is that provision of the recommended vaccination schedule to all eligible individuals … Product reports can be submitted by sending an email accompanied by photos to support.lcc@rivm.nl . The person who … workdays . Of course, the National Coordination Centre for Communicable Diseases Control (LCI) can be reached 24/7 for …

    Publication date: 09-07-2021
  • Results of the Pienter Corona Study Round 6

    https://www.rivm.nl/en/pienter-corona-study/results/round-6

    … (against all kinds of infectious diseases) is lower compared to the rest of the Netherlands.   The number of … background are slightly more likely to have antibodies compared to people with a non-Western migration background. … established by looking at different types of antibodies in combination with information from the questionnaire. In …

    Publication date: 04-23-2024
  • Issue 17

    https://www.rivm.nl/en/covid-19-vaccination/professionals/newsletter/2021/17

    … Communication resources for various targets groups … specific target group based on national and international recommendations. Since we want to vaccinate as many people as … be vaccinated? When can this take place? It is now recommended that pregnant women be routinely vaccinated, when …

    Publication date: 05-10-2021
  • Newsletter on COVID-19 vaccination issue 8 2021

    https://www.rivm.nl/en/covid-19-vaccination/professionals/newsletter/2021/8

    … Public communication … Upcoming events … older people living at home have been on the rise again compared to two weeks ago. The continued significant … nausea and vomiting may also occur after vaccination with Comirnaty (Pfizer/BioNTech), Moderna and AstraZeneca … (in number and severity) in response to the mRNA vaccines (Comirnaty and Moderna). The AstraZeneca vaccine can also …

    Publication date: 03-01-2021
  • Newsletter on COVID-19 vaccination issue 5 2021

    https://www.rivm.nl/en/covid-19-vaccination/professionals/newsletter/2021/5

    … Medicines Agency (EMA) issued a positive scientific recommendation for the third COVID-19 vaccine in the European … with the University of Oxford. That same day, the European Commission announced that it had approved the vaccine for … strategy as it is currently planned.   Interval for Comirnaty® (Pfizer/BioNTech) The Health Council of the …

    Publication date: 02-11-2021
  • Issue 33

    https://www.rivm.nl/en/covid-19-vaccination/professionals/newsletter/2021/33

    … Public communication … who have an allergic reaction to the COVID-19 vaccine or a component of the vaccine have a provisional contraindication … for vaccination. This option replaces the previous recommendation not to vaccinate in the event of an allergic … Evaluation starts for use of COVID-19 vaccine Comirnaty (Pfizer) in children aged 5 to 11 years The …

    Publication date: 10-26-2021
  • News and activities WHO CC for Tobacco Product Regulation and Control

    https://www.rivm.nl/en/who-collaborating-centre-for-tobacco-product-regulation-and-control/news

    … is to develop and validate chemical analytical methods for components in tobacco- and nicotine products, both in … was to prepare all the laboratories participating in the upcoming HTP testing round-robin study in 2026 on the analysis … booth throughout the week. Besides, RIVM officers visited the Gorgas Research Institute, with the Dutch Deputy …

    Publication date: 06-02-2014
  • Current information about hantavirus

    https://www.rivm.nl/en/hantavirus/current-information

    … ill live near nature or forested areas or meadows, or visit these areas often. When asked, they mentioned activities during which they might have come into contact with dust from mouse droppings containing … of once a week for the presence of the Andes virus in the coming period. In addition, multiple bodily materials are …

    Publication date: 05-05-2026
  • Newsletter on COVID-19 vaccination issue 6 2021

    https://www.rivm.nl/en/covid-19-vaccination/professionals/newsletter/2021/6

    … Comparison with other countries … Public communication … Upcoming events … Situation Dashboard shows the progress in the Netherlands compared to other countries: After a slightly later start, … define the group of people with a neurological condition in combination with respiratory problems. This round of …

    Publication date: 02-16-2021
  • Issue 25

    https://www.rivm.nl/en/covid-19-vaccination/professionals/newsletter/2021/25

    … Public communication … states that an interval of at least 21 days is used for Comirnaty® (Pfizer/BioNTech) and 28 days for Spikevax® … available at the Municipal Public Health Services (GGDs). A communication from GGD GHOR Netherlands will provide more … have a second vaccination with the Pfizer/BioNTech vaccine (Comirnaty®), can make an appointment for vaccination by the …

    Publication date: 07-19-2021
  • Results of the Pienter Corona Study Round 7

    https://www.rivm.nl/en/pienter-corona-study/results/round-7

    … (against all kinds of infectious diseases) is lower compared to the rest of the Netherlands. The number of … established by looking at different types of antibodies in combination with information from the questionnaire and … from previous rounds. In addition, some people also become infected after vaccination. As seen in rounds 4–6, the …

    Publication date: 04-23-2024
  • RIVM reports

    https://www.rivm.nl/en/about-rivm/corporate-publications/rivm-reports

    … exploratory study into the possibilities and limitations, commissioned by the Ministry of Health, Welfare and Sport … nitrogen concentrations and deposition on a local scale. Comparison of eight models and their ensembles with three … report Prioritisation of substances for health-based recommended exposure limits in Health Council work programme …

    Publication date: 01-15-2019
  • Newsletter on COVID-19 vaccination issue 4 2021

    https://www.rivm.nl/en/covid-19-vaccination/professionals/newsletter/2021/4

    … Public communication … Upcoming events … so they must be kept in stock at the location. It is recommended to vaccinate with a longer needle (38 mm) if: 1. … the skin fold, a longer needle is needed. Note: If someone comes in for the 2nd vaccination, and turns out to need a …

    Publication date: 01-29-2021
  • Issue 32

    https://www.rivm.nl/en/covid-19-vaccination/professionals/newsletter/2021/32

    … Public communication … for an extra dose (third jab) or booster dose. Read the recommendations of EMA’s human medicines committee , and the subsequent recommendations of the Medicines Evaluation Board (CBG-MEB) . … COVID-19 vaccination in combination with other vaccinations  Do you have an …

    Publication date: 10-13-2021
  • RIVM reports and knowledge briefs

    https://www.rivm.nl/en/about-rivm/corporate-publications/reports-and-knowledge-briefs

    … report Gasping for air. Asphyxiation hazards at work report Comparison of bulk and wet-only deposition measurements of … Title  Type Risks from combinations of substances: overview of assessment methods … exploratory study into the possibilities and limitations, commissioned by the Ministry of Health, Welfare and Sport …

    Publication date: 03-31-2026
  • Issue 18

    https://www.rivm.nl/en/covid-19-vaccination/professionals/newsletter/2021/18

    … vial using Vernacare needle and SJJ needle-syringe combination … Public communication … municipalities, Municipal Public Health Services (GGDs) and communities are making an extra effort to reach and provide … data. It therefore advises following the interval recommended in the product information: between 4 and 12 …

    Publication date: 05-25-2021
  • Issue 24

    https://www.rivm.nl/en/covid-19-vaccination/professionals/newsletter/2021/24

    … Public communication … tiredness, chills, headaches and muscle aches after the combination of two different vaccines. The practical effects … and safety of heterologous vaccination with other vaccine combinations. … with the BioNTech/Pfizer vaccine is the only approved combination; other vaccine combinations are not possible, …

    Publication date: 07-15-2021

Pagination

  • « First
  • ‹ Previous
  • …
  • Page 24
  • Page 25
  • Page 26
  • Page 27
  • Page 28
  • Page 29
  • Page 30
  • Current page 31
  • Page 32
  • › Next
  • » Last

Service

  • Contact
  • Information for the press
  • Working for RIVM
  • Complaints
  • Submitting WOO requests to RIVM
  • Doing business with RIVM
  • Social media house rules

About this site

  • Cookies
  • Privacy
  • Accessibility
  • Disclaimer and copyright
  • Coordinated Vulnerability Disclosure
  • Website archive

Languages

  • English
  • Nederlands

Follow us

  • RIVM Newsletters
  • RSS feed
  • X Twitter
  • Facebook
  • LinkedIn
  • Youtube
  • Instagram
  • Mastodon